Selected research
Market Outlook & Growth Opportunities
Global Home Pet Deworming Medicine Market Outlook and Growth Opportunities 2026
Market perspective
The global Home Pet Deworming Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Home Pet Deworming Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Home Pet Deworming Medicine market include Zoetis, Merck & Co, Inc., Sava Healthcare Limited, Boehringer Ingelheim International GmbH, Ceva, Elanco, Virbac, PetIQ, LLC and Liquid Fence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Home Pet Deworming Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Home Pet Deworming Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Home Pet Deworming Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Pet Deworming Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Home Pet Deworming Medicine Segment by Company
Zoetis
Merck & Co, Inc.
Sava Healthcare Limited
Boehringer Ingelheim International GmbH
Ceva
Elanco
Virbac
PetIQ, LLC
Liquid Fence
Bird-X
HortiCentre
Green Gardener
The Big Cheese
Yorkshire Trading Company
Ramical
Beaphar
Agland
Home Pet Deworming Medicine Segment by Type
Internal Deworming
External Deworming
Home Pet Deworming Medicine Segment by Application
Cats
Dogs
Others
Home Pet Deworming Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Home Pet Deworming Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Home Pet Deworming Medicine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Home Pet Deworming Medicine significant trends, drivers, influence factors in global and regions.
6. To analyze Home Pet Deworming Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Pet Deworming Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Pet Deworming Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Pet Deworming Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Home Pet Deworming Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Home Pet Deworming Medicine industry.
Chapter 3: Detailed analysis of Home Pet Deworming Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Home Pet Deworming Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Home Pet Deworming Medicine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Internal Deworming
- External Deworming
Applications
- Cats
- Dogs
- Others
Companies covered
- Zoetis
- Merck & Co, Inc.
- Sava Healthcare Limited
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- Virbac
- PetIQ, LLC
- Liquid Fence
- Bird-X
- HortiCentre
- Green Gardener
- The Big Cheese
- Yorkshire Trading Company
- Ramical
- Beaphar
- Agland
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Home Pet Deworming Medicine Sales Value (2021-2032)
- 1.2.2 Global Home Pet Deworming Medicine Sales Volume (2021-2032)
- 1.2.3 Global Home Pet Deworming Medicine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Home Pet Deworming Medicine Market Dynamics
- 2.1 Home Pet Deworming Medicine Industry Trends
- 2.2 Home Pet Deworming Medicine Industry Drivers
- 2.3 Home Pet Deworming Medicine Industry Opportunities and Challenges
- 2.4 Home Pet Deworming Medicine Industry Restraints
3 Home Pet Deworming Medicine Market by Company
- 3.1 Global Home Pet Deworming Medicine Company Revenue Ranking in 2025
- 3.2 Global Home Pet Deworming Medicine Revenue by Company (2021-2026)
- 3.3 Global Home Pet Deworming Medicine Sales Volume by Company (2021-2026)
- 3.4 Global Home Pet Deworming Medicine Average Price by Company (2021-2026)
- 3.5 Global Home Pet Deworming Medicine Company Ranking (2024-2026)
- 3.6 Global Home Pet Deworming Medicine Company Manufacturing Base and Headquarters
- 3.7 Global Home Pet Deworming Medicine Company Product Type and Application
- 3.8 Global Home Pet Deworming Medicine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Home Pet Deworming Medicine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Home Pet Deworming Medicine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Home Pet Deworming Medicine Market by Type
- 4.1 Home Pet Deworming Medicine Type Introduction
- 4.1.1 Internal Deworming
- 4.1.2 External Deworming
- 4.2 Global Home Pet Deworming Medicine Sales Volume by Type
- 4.2.1 Global Home Pet Deworming Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Home Pet Deworming Medicine Sales Volume by Type (2021-2032)
- 4.2.3 Global Home Pet Deworming Medicine Sales Volume Share by Type (2021-2032)
- 4.3 Global Home Pet Deworming Medicine Sales Value by Type
- 4.3.1 Global Home Pet Deworming Medicine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Home Pet Deworming Medicine Sales Value by Type (2021-2032)
- 4.3.3 Global Home Pet Deworming Medicine Sales Value Share by Type (2021-2032)
5 Home Pet Deworming Medicine Market by Application
- 5.1 Home Pet Deworming Medicine Application Introduction
- 5.1.1 Cats
- 5.1.2 Dogs
- 5.1.3 Others
- 5.2 Global Home Pet Deworming Medicine Sales Volume by Application
- 5.2.1 Global Home Pet Deworming Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Home Pet Deworming Medicine Sales Volume by Application (2021-2032)
- 5.2.3 Global Home Pet Deworming Medicine Sales Volume Share by Application (2021-2032)
- 5.3 Global Home Pet Deworming Medicine Sales Value by Application
- 5.3.1 Global Home Pet Deworming Medicine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Home Pet Deworming Medicine Sales Value by Application (2021-2032)
- 5.3.3 Global Home Pet Deworming Medicine Sales Value Share by Application (2021-2032)
6 Home Pet Deworming Medicine Regional Sales and Value Analysis
- 6.1 Global Home Pet Deworming Medicine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Home Pet Deworming Medicine Sales by Region (2021-2032)
- 6.2.1 Global Home Pet Deworming Medicine Sales by Region: 2021-2026
- 6.2.2 Global Home Pet Deworming Medicine Sales by Region (2027-2032)
- 6.3 Global Home Pet Deworming Medicine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Home Pet Deworming Medicine Sales Value by Region (2021-2032)
- 6.4.1 Global Home Pet Deworming Medicine Sales Value by Region: 2021-2026
- 6.4.2 Global Home Pet Deworming Medicine Sales Value by Region (2027-2032)
- 6.5 Global Home Pet Deworming Medicine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Home Pet Deworming Medicine Sales Value (2021-2032)
- 6.6.2 North America Home Pet Deworming Medicine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Home Pet Deworming Medicine Sales Value (2021-2032)
- 6.7.2 Europe Home Pet Deworming Medicine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Home Pet Deworming Medicine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Home Pet Deworming Medicine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Home Pet Deworming Medicine Sales Value (2021-2032)
- 6.9.2 South America Home Pet Deworming Medicine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Home Pet Deworming Medicine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Home Pet Deworming Medicine Sales Value Share by Country, 2025 VS 2032
7 Home Pet Deworming Medicine Country-level Sales and Value Analysis
- 7.1 Global Home Pet Deworming Medicine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Home Pet Deworming Medicine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Home Pet Deworming Medicine Sales by Country (2021-2032)
- 7.3.1 Global Home Pet Deworming Medicine Sales by Country (2021-2026)
- 7.3.2 Global Home Pet Deworming Medicine Sales by Country (2027-2032)
- 7.4 Global Home Pet Deworming Medicine Sales Value by Country (2021-2032)
- 7.4.1 Global Home Pet Deworming Medicine Sales Value by Country (2021-2026)
- 7.4.2 Global Home Pet Deworming Medicine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Home Pet Deworming Medicine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Home Pet Deworming Medicine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Home Pet Deworming Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis
- 8.1.1 Zoetis Company Information
- 8.1.2 Zoetis Business Overview
- 8.1.3 Zoetis Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Zoetis Home Pet Deworming Medicine Product Portfolio
- 8.1.5 Zoetis Recent Developments
- 8.2 Merck & Co, Inc.
- 8.2.1 Merck & Co, Inc. Company Information
- 8.2.2 Merck & Co, Inc. Business Overview
- 8.2.3 Merck & Co, Inc. Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Merck & Co, Inc. Home Pet Deworming Medicine Product Portfolio
- 8.2.5 Merck & Co, Inc. Recent Developments
- 8.3 Sava Healthcare Limited
- 8.3.1 Sava Healthcare Limited Company Information
- 8.3.2 Sava Healthcare Limited Business Overview
- 8.3.3 Sava Healthcare Limited Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Sava Healthcare Limited Home Pet Deworming Medicine Product Portfolio
- 8.3.5 Sava Healthcare Limited Recent Developments
- 8.4 Boehringer Ingelheim International GmbH
- 8.4.1 Boehringer Ingelheim International GmbH Company Information
- 8.4.2 Boehringer Ingelheim International GmbH Business Overview
- 8.4.3 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Product Portfolio
- 8.4.5 Boehringer Ingelheim International GmbH Recent Developments
- 8.5 Ceva
- 8.5.1 Ceva Company Information
- 8.5.2 Ceva Business Overview
- 8.5.3 Ceva Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Ceva Home Pet Deworming Medicine Product Portfolio
- 8.5.5 Ceva Recent Developments
- 8.6 Elanco
- 8.6.1 Elanco Company Information
- 8.6.2 Elanco Business Overview
- 8.6.3 Elanco Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Elanco Home Pet Deworming Medicine Product Portfolio
- 8.6.5 Elanco Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Virbac Home Pet Deworming Medicine Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 PetIQ, LLC
- 8.8.1 PetIQ, LLC Company Information
- 8.8.2 PetIQ, LLC Business Overview
- 8.8.3 PetIQ, LLC Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.8.4 PetIQ, LLC Home Pet Deworming Medicine Product Portfolio
- 8.8.5 PetIQ, LLC Recent Developments
- 8.9 Liquid Fence
- 8.9.1 Liquid Fence Company Information
- 8.9.2 Liquid Fence Business Overview
- 8.9.3 Liquid Fence Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Liquid Fence Home Pet Deworming Medicine Product Portfolio
- 8.9.5 Liquid Fence Recent Developments
- 8.10 Bird-X
- 8.10.1 Bird-X Company Information
- 8.10.2 Bird-X Business Overview
- 8.10.3 Bird-X Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Bird-X Home Pet Deworming Medicine Product Portfolio
- 8.10.5 Bird-X Recent Developments
- 8.11 HortiCentre
- 8.11.1 HortiCentre Company Information
- 8.11.2 HortiCentre Business Overview
- 8.11.3 HortiCentre Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.11.4 HortiCentre Home Pet Deworming Medicine Product Portfolio
- 8.11.5 HortiCentre Recent Developments
- 8.12 Green Gardener
- 8.12.1 Green Gardener Company Information
- 8.12.2 Green Gardener Business Overview
- 8.12.3 Green Gardener Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Green Gardener Home Pet Deworming Medicine Product Portfolio
- 8.12.5 Green Gardener Recent Developments
- 8.13 The Big Cheese
- 8.13.1 The Big Cheese Company Information
- 8.13.2 The Big Cheese Business Overview
- 8.13.3 The Big Cheese Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.13.4 The Big Cheese Home Pet Deworming Medicine Product Portfolio
- 8.13.5 The Big Cheese Recent Developments
- 8.14 Yorkshire Trading Company
- 8.14.1 Yorkshire Trading Company Company Information
- 8.14.2 Yorkshire Trading Company Business Overview
- 8.14.3 Yorkshire Trading Company Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Yorkshire Trading Company Home Pet Deworming Medicine Product Portfolio
- 8.14.5 Yorkshire Trading Company Recent Developments
- 8.15 Ramical
- 8.15.1 Ramical Company Information
- 8.15.2 Ramical Business Overview
- 8.15.3 Ramical Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Ramical Home Pet Deworming Medicine Product Portfolio
- 8.15.5 Ramical Recent Developments
- 8.16 Beaphar
- 8.16.1 Beaphar Company Information
- 8.16.2 Beaphar Business Overview
- 8.16.3 Beaphar Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Beaphar Home Pet Deworming Medicine Product Portfolio
- 8.16.5 Beaphar Recent Developments
- 8.17 Agland
- 8.17.1 Agland Company Information
- 8.17.2 Agland Business Overview
- 8.17.3 Agland Home Pet Deworming Medicine Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Agland Home Pet Deworming Medicine Product Portfolio
- 8.17.5 Agland Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Home Pet Deworming Medicine Value Chain Analysis
- 9.1.1 Home Pet Deworming Medicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Home Pet Deworming Medicine Sales Mode & Process
- 9.2 Home Pet Deworming Medicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Home Pet Deworming Medicine Distributors
- 9.2.3 Home Pet Deworming Medicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst